Telefon:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@antikoerper-online.de

Ataxin 1 Antikörper (AA 645-815)

Dieses Maus Monoklonal-Antikörper erkennt spezifisch Ataxin 1 in WB, ELISA und FACS. Er zeigt eine Reaktivität gegenüber Human und Maus.
Produktnummer ABIN7193320

Kurzübersicht für Ataxin 1 Antikörper (AA 645-815) (ABIN7193320)

Target

Alle Ataxin 1 (ATXN1) Antikörper anzeigen
Ataxin 1 (ATXN1)

Reaktivität

  • 78
  • 63
  • 35
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
Human, Maus

Wirt

  • 67
  • 51
  • 1
Maus

Klonalität

  • 67
  • 52
Monoklonal

Konjugat

  • 50
  • 8
  • 7
  • 7
  • 5
  • 4
  • 3
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
Dieser Ataxin 1 Antikörper ist unkonjugiert

Applikation

  • 88
  • 45
  • 43
  • 36
  • 34
  • 25
  • 23
  • 23
  • 9
  • 6
  • 5
  • 1
  • 1
Western Blotting (WB), ELISA, Flow Cytometry (FACS)

Klon

2B8A2
  • Bindungsspezifität

    • 28
    • 22
    • 17
    • 12
    • 7
    • 3
    • 3
    • 2
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    AA 645-815

    Verwendungszweck

    ATXN1 Antibody

    Aufreinigung

    Purified antibody

    Immunogen

    Purified recombinant fragment of human ATXN1 (AA: 645-815) expressed in E. Coli.

    Isotyp

    IgG1
  • Applikationshinweise

    ELISA: 1/10000

    FCM: 1/200 - 1/400

    Beschränkungen

    Nur für Forschungszwecke einsetzbar
  • Format

    Liquid

    Buffer

    Purified antibody in PBS with 0.05 % sodium azide.

    Konservierungsmittel

    Sodium azide

    Vorsichtsmaßnahmen

    This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

    Lagerung

    4 °C,-20 °C

    Informationen zur Lagerung

    Store at 4°C short term. Aliquot and store at -20°C long term. Avoid freeze/thaw cycles.
  • Target

    Ataxin 1 (ATXN1)

    Andere Bezeichnung

    ATXN1

    Hintergrund

    The autosomal dominant cerebellar ataxias (ADCA) are a heterogeneous group of neurodegenerative disorders characterized by progressive degeneration of the cerebellum, brain stem and spinal cord. Clinically, ADCA has been divided into three groups: ADCA types I-III. ADCAI is genetically heterogeneous, with five genetic loci, designated spinocerebellar ataxia (SCA) 1, 2, 3, 4 and 6, being assigned to five different chromosomes. ADCAII, which always presents with retinal degeneration (SCA7), and ADCAIII often referred to as the `pure' cerebellar syndrome (SCA5), are most likely homogeneous disorders. Several SCA genes have been cloned and shown to contain CAG repeats in their coding regions. ADCA is caused by the expansion of the CAG repeats, producing an elongated polyglutamine tract in the corresponding protein. The expanded repeats are variable in size and unstable, usually increasing in size when transmitted to successive generations. The function of the ataxins is not known. This locus has been mapped to chromosome 6, and it has been determined that the diseased allele contains 40-83 CAG repeats, compared to 6-39 in the normal allele, and is associated with spinocerebellar ataxia type 1 (SCA1). Alternative splicing results in multiple transcript variants, with one variant encoding multiple distinct proteins, ATXN1 and Alt-ATXN1, due to the use of overlapping alternate reading frames.

    Molekulargewicht

    86.9 kDa

    UniProt

    P54253

    Pathways

    Synaptic Membrane
Sie sind hier:
Chat with us!